Concepedia

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

Evandro de Azambuja, Worta McCaskill‐Stevens, Prudence A. Francis, Emmanuel Quinaux, John Crown, Malou Vicente, R. Giuliani, Bo Nordenskjöld, Jorge Gutiérez, Michael Andersson,

Breast Cancer Research and Treatment · 2009 · 160 citations · 22 references

Concepts

MedicineOncologyBreast OncologyChemotherapyMedical OncologyAdjuvant ChemotherapyAdjuvant PharmacotherapyAdjuvant TherapyBreast Cancer OncologyBreast Cancer PharmacotherapyNeoadjuvant ChemotherapyBreast Cancer ChemotherapyDisease-free Survival AnalysisDisease-free Survival AssessmentDoxorubicin-based TherapyHigh-risk Node-negative Breast CancerLow Body Mass Index

References

22

Regression Models and Life-Tables

D. R. Cox · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 39.3K citations · Full text

Public Health, Biostatistics, Hazard Identification +16

Estimates of the cancer incidence and mortality in Europe in 2006

Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology · 2007 · 4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +11

Cancer incidence, mortality and prevalence worldwide

J Ferlay · Medical Entomology and Zoology · 2004 · 3.8K citations

Medicine, Oncology, Cancer Epidemiology +13

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

Medicine, Oncology, Pharmacology +13

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

Henri Roché, P. Fumoleau, M. Spielmann et al. · Journal of Clinical Oncology · 2006 · 572 citations · Full text

Medicine, Oncology, Pharmacology +16